Compare, Analyse AMAR REMEDIES with HYPERMARCAS SA - Brazil - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

AMAR REMEDIES vs HYPERMARCAS (Brazil) - Comparison Results

HYPERMARCAS (Brazil)
   Change

Hypermarcas SA is a leading consumer goods company in Brazil. The company is present in pharmaceuticals and personal care. The company's pharmaceuticals products include over-the-counter medications, generic drugs and prescription medications. The c... More

DO YOU LIKE THESE REPORTS? TELL US!

Financials

 AMAR REMEDIES   HYPERMARCAS
EQUITY SHARE DATA
    AMAR REMEDIES
Jun-12
HYPERMARCAS
Dec-14
AMAR REMEDIES/
HYPERMARCAS
5-Yr Chart
Click to enlarge
High Rs164319-   
Low Rs86234-   
Sales per share (Unadj.) Rs261.6109.0-  
Earnings per share (Unadj.) Rs17.49.6-  
Cash flow per share (Unadj.) Rs22.312.1-  
Dividends per share (Unadj.) Rs00-  
Dividend yield (eoy) %00-  
Book value per share (Unadj.) Rs100.7174.1-  
Shares outstanding (eoy) m26.16635.00-   
Bonus/Rights/Conversions ---  
Price / Sales ratio x0.52.5 18.8%   
Avg P/E ratio x7.228.8 24.9%  
P/CF ratio (eoy) x5.622.8 24.6%  
Price / Book Value ratio x1.21.6 78.1%  
Dividend payout %00-   
Avg Mkt Cap Rs m3,270175,624 1.9%   
No. of employees `000NA12.9 0.0%   
Total wages/salary Rs m1633,387 4.8%   
Avg. sales/employee Rs ThNM5,351.2-  
Avg. wages/employee Rs ThNM261.8-  
Avg. net profit/employee Rs ThNM471.1-  
INCOME DATA
Net Sales Rs m6,84469,217 9.9%  
Other income Rs m211,169 1.8%   
Total revenues Rs m6,86570,386 9.8%   
Gross profit Rs m1,13116,706 6.8%  
Depreciation Rs m1281,620 7.9%   
Interest Rs m3988,815 4.5%   
Profit before tax Rs m6267,439 8.4%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m-50-148 33.8%   
Tax Rs m1211,198 10.1%   
Profit after tax Rs m4556,093 7.5%  
Gross profit margin %16.524.1 68.5%  
Effective tax rate %19.316.1 120.0%   
Net profit margin %6.68.8 75.5%  
BALANCE SHEET DATA
Current assets Rs m4,90471,362 6.9%   
Current liabilities Rs m3,58144,207 8.1%   
Net working cap to sales %19.339.2 49.3%  
Current ratio x1.41.6 84.8%  
Inventory Days Days12452 241.0%  
Debtors Days Days100121 82.6%  
Net fixed assets Rs m1,68924,655 6.9%   
Share capital Rs m26277,840 0.3%   
"Free" reserves Rs m2,3580-   
Net worth Rs m2,635110,570 2.4%   
Long term debt Rs m50745,464 1.1%   
Total assets Rs m6,862205,404 3.3%  
Interest coverage x2.61.8 139.5%   
Debt to equity ratio x0.20.4 46.8%  
Sales to assets ratio x1.00.3 296.0%   
Return on assets %12.47.3 171.3%  
Return on equity %17.35.5 313.3%  
Return on capital %31.010.3 300.3%  
Exports to sales %4.00-   
Imports to sales %00-   
Net fx Rs m2710-   
CASH FLOW
From Operations Rs m-3139,821 -3.2%  
From Investments Rs m-4891,009 -48.4%  
From Financial Activity Rs m769-905 -84.9%  
Net Cashflow Rs m-339,926 -0.3%  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster
The reporting currency for HYPERMARCAS (Brazil) is Brazil Reais. All data has been converted at 14.79 Rs / BRL

Compare AMAR REMEDIES With: P&G (US)  UNILEVER PLC. (UK)  

Compare AMAR REMEDIES With: EMAMI LTD  MARICO  KARUTURI GLOBAL  HUL  LINC PEN & PLASTICS  



Today's Market

Sensex Tanks 1,375 Points; Nifty Ends Below 8,300 Mark(Closing)

Indian share markets witnessed selling pressure throughout the day and ended deep in the red with Sensex and Nifty witnessing a sharp fall during closing hours.

Related Views On News

Most Popular

This Crorepati Stock Could Be the Best Vaccine for Your Portfolio Against Coronavirus (Profit Hunter)

Mar 17, 2020

If there is one stock I had to recommend you amid Coronavirus outbreak, this would be it.

If I Were to Recommend One Stock Amid Coronavirus Outbreak, This Would be It. (Profit Hunter)

Mar 19, 2020

Coronavirus outbreak has made no impact on the long term prospects of my favourite smallcap. What it has indeed done is brought the company below my buy price, making it even more attractive investment at current price.

Why India Will Be the Biggest Winner in a Post-Coronavirus World (The 5 Minute Wrapup)

Mar 19, 2020

The way businesses operate will change in a major way post the coronavirus impact. Here's why India stands to benefit from this change...

A Big Trading Opportunity is Coming Your Way Soon (Fast Profits Daily)

Mar 25, 2020

I see a big opportunity to make fast profits on the horizon.

The Biggest Trading Opportunity of 2020 is Here...

Mar 26, 2020

India's #1 trader, Vijay Bhambwani, talks about a hugely profitable trading opportunity which you must know about today!

More

How to Trade the
Coronavirus Crash

Coronavirus Crash
Get this special report, authored by Equitymaster's top analysts, now.
We will never sell or rent your email id.
Please read our Terms

OUR TOP 5 IDEAS

How to Trade the Coronavirus Crash - Download this FREE Report Now
How to Profit Even During These Times of Crisis: Vijay Bhambwani Reveals his Strategy...
The Best Stocks For 2020 - How to Spot Multibagger Ideas. FREE Sign up!
Free Report: The Secret to Increasing Your Trading Profits Daily!
Find Out Our Top 7 Bluechips for 2020 Virtually FREE. Click Here Now!

AMAR REMEDIES SHARE PRICE


Dec 11, 2013 (Close)

TRACK AMAR REMEDIES

  • Track your investment in AMAR REMEDIES with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON AMAR REMEDIES

AMAR REMEDIES 5-YR ANALYSIS

COMPARE AMAR REMEDIES WITH

OTHER USEFUL LINKS

MARKET STATS